Alvin Katumba: Sickle Cell Disease Research Recognised With a 2026 ASH Abstract Achievement Award
Alvin Katumba, Clinical Research Fellow in Sickle Cell Disease at Guy’s and St Thomas’ NHS Foundation Trust, shared a post on LinkedIn:
”Delighted to share that our research in sickle cell disease has been accepted for presentation at the 68th American Society of Hematology (ASH) Annual Meeting in New Orleans this December, and has been recognised with a 2026 ASH Abstract Achievement Award.
By harmonising real-world data from over 4,000 patients across independent UK and US cohorts, we explored differences in disease-modifying treatment exposure, laboratory markers and acute healthcare utilisation.
Our findings highlight the persistent burden of sickle cell disease despite current treatments, reinforcing the need for continued research and improved approaches to patient care.
A huge thank you to all our colleagues and collaborators across the UK and US who contributed to this work.
Looking forward to sharing our findings in New Orleans and exploring opportunities for further collaboration!”

Stay updated with Hemostasis Today.
-
Nov 18, 2026, 13:34Vincenzo De Angelis: Strengthening Plasma Management and Quality Control in Eastern Europe
-
Nov 18, 2026, 13:34Standardizing Bleeding Outcome Assessment in Hemophilia Clinical Trials – JTH
-
Nov 18, 2026, 13:34Nicolas Gendron: Towards Sustainable Anticoagulation
-
Nov 18, 2026, 13:33Breaking the Silence on Women and Girls with Bleeding Disorders – EHC
-
Nov 18, 2026, 13:32Maria Elisa Mancuso: Next-Generation Protein Therapies in Hemophilia
-
Nov 18, 2026, 13:25Maia Meier: Advocating for Women and Girls with Bleeding Disorders
-
Nov 18, 2026, 13:19Sjoerd Fabian Koopman: Exploring Tissue Distribution of Extended Half-Life Factor IX Concentrates
-
Nov 18, 2026, 13:16Ifeanyichukwu Ifechidere: Choosing Between Clot-Based and Chromogenic Coagulation Assays
-
Nov 18, 2026, 13:06Saurabh Mehta: Daily Iron Supplementation in Children and Adolescents